Cite
HARVARD Citation
Fowler, E. et al. (2020). Risk of tuberculosis reactivation during interleukin‐17 inhibitor therapy for psoriasis: a systematic review. Journal of the European Academy of Dermatology and Venereology. pp. 1449-1456. [Online].